|
Variable
|
Subgroup
|
No. of patients
|
%
|
|---|
|
Sex
|
Male
|
125
|
65.8
|
| |
Female
|
65
|
34.2
|
|
Age
|
Median
|
55 years
| |
| |
Range
|
(24–79 years)
| |
|
ECOG performance status
|
0,1
|
186
|
97.9
|
| |
2
|
4
|
2.1
|
|
Lauren
|
Intestinal
|
26
|
13.7
|
| |
Diffuse
|
41
|
21.6
|
| |
Mixed
|
18
|
9.5
|
| |
Unknown
|
105
|
55.3
|
|
Initial stage
|
1
|
8
|
4.2
|
| |
2
|
28
|
14.7
|
| |
3
|
41
|
21.6
|
| |
4
|
113
|
59.5
|
|
Operation
|
+
|
127
|
66.8
|
| |
-
|
63
|
33.2
|
|
Adjuvant therapy
|
+
|
79
|
41.6
|
| |
-
|
111
|
58.4
|
|
No. of metastasis
|
1
|
106
|
55.8
|
| |
2
|
54
|
28.4
|
| |
> 3
|
30
|
15.8
|
|
CEA
|
< 5 ng/ml
|
119
|
62.6
|
| |
≥ 5 ng/ml
|
54
|
28.4
|
| |
Unchecked
|
17
|
8.9
|
- ECOG: eastern cooperative oncology group, CEA: carcinoembryonic antigen.
